We are live on ! Find out more
COGT icon

Cogent Biosciences
COGT

35 hedge funds and large institutions have $91M invested in Cogent Biosciences in 2020 Q3 according to their latest regulatory filings, with 17 funds opening new positions, 6 increasing their positions, 7 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,860% more capital invested

Capital invested by funds: $4.64M → $91M (+$86.3M)

300% more funds holding in top 10

Funds holding in top 10: 1 → 4 (+3)

183% more first-time investments, than exits

New positions opened: 17 | Existing positions closed: 6

46% more funds holding

Funds holding: 24 → 35 (+11)

15.76% more ownership

Funds ownership: 8.1% → 23.86% (+16%)

14% less repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 7

Holders
35
Holders Change
+11
Holders Change %
+45.83%
% of All Funds
0.71%
Holding in Top 10
4
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+300%
% of All Funds
0.08%
New
17
Increased
6
Reduced
7
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
PA
Perceptive Advisors
New York
+$20.7M
2
FFM
Fairmount Funds Management
Pennsylvania
+$16.3M
3
SB
Samsara BioCapital
California
+$14.8M
4
VA
VR Adviser
New York
+$11.4M
5
LGM
Logos Global Management
California
+$7.04M

Top Sellers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
-$2.2M
2
CA
CHI Advisors
New York
-$433K
3
Fidelity International
Fidelity International
Bermuda
-$313K
4
BlackRock
BlackRock
New York
-$178K
5
Acadian Asset Management
Acadian Asset Management
Massachusetts
-$64.7K
Name Holding Trade Value Shares
Change 		Change in
Stake
Northern Trust
26
Northern Trust
Illinois
$65K +$16K +1,537 +29%
Citadel Advisors
27
Citadel Advisors
Florida
$59K +$23.5K +2,250 +56%
Dimensional Fund Advisors
28
Dimensional Fund Advisors
Texas
$56K +$62.2K +5,964 New
DTL
29
Dynamic Technology Lab
Singapore
$26K +$29.3K +2,815 New
TRCT
30
Tower Research Capital (TRC)
New York
$21K -$19.1K -1,830 -45%
Bank Julius Baer & Co
31
Bank Julius Baer & Co
Switzerland
$5K – – –
PFGIA
32
Patriot Financial Group Insurance Agency
Massachusetts
$3K – – –
Millennium Management
33
Millennium Management
New York
$2.83K +$3.15M +302,373 New
UBS Group
34
UBS Group
Switzerland
$1K +$886 +85 New
CA
35
CHI Advisors
New York
– -$433K -235,201 Closed
Fidelity International
36
Fidelity International
Bermuda
– -$313K -169,931 Closed
Barclays
37
Barclays
United Kingdom
– -$3K -1,869 Closed
PAG
38
Private Advisor Group
New Jersey
– -$2K -1,125 Closed
BNP Paribas Financial Markets
39
BNP Paribas Financial Markets
France
– -$17 -10 Closed
Wells Fargo
40
Wells Fargo
California
– +$115 +11 +50%
1
2

COGT Hedge Fund Activity: Q3 2020 in Review

35 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in Cogent Biosciences (COGT) for Q3 2020, worth a combined $91M — up 1,860% from $4.64M a quarter earlier.

Buyers outnumbered sellers: 17 funds opened new COGT positions and 6 closed out — a net gain of 11 holders — while 6 added to existing stakes and 7 trimmed.

The largest buyer was Perceptive Advisors, opening a new position worth an estimated $20.7M. The largest seller was Renaissance Technologies, cutting an estimated $2.2M.

  • 35 institutional investors held Cogent Biosciences (COGT) as of Q3 2020, up from 24 in Q2 2020.
  • Funds reported $91M of Cogent Biosciences stock for Q3 2020, up 1,860% quarter-over-quarter.
  • 17 funds opened new Cogent Biosciences positions in Q3 2020 and 6 closed out, a net change of +11 holders.
  • The largest Cogent Biosciences buyer in Q3 2020 was Perceptive Advisors, an estimated $20.7M added.
  • The largest Cogent Biosciences seller in Q3 2020 was Renaissance Technologies, an estimated $2.2M sold.

Based on aggregated 13F filings for Q3 2020.